Oncosec Medical Incorporated Net Income per Employee (ONCS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Oncosec Medical Incorporated  (NASDAQ: ONCS)
 

Oncosec Medical Incorporated Net Income per Employee

ONCS's Quarterly Results, Trends, Rankings, Statistics
Oncosec Medical Incorporated recorded a cumulative net loss of $-29 million during 12 month ending in the second quarter 2023.
The Healthcare sector has seen employees of 447 other companies achieving higher income per employee. While Oncosec Medical Incorporated's total ranking has deteriorated compared to the previous quarter from 0 to 4720.


What is Income per Employee Ratio?






ONCS Net Income per Employee (Jan 31 2023)
II. Quarter
(Oct 31 2022)
I. Quarter
(Jul 31 2022)
IV. Quarter
(Apr 30 2022)
III. Quarter
(Jan 31 2022)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,959,058 -2,162,160 -2,278,642 -2,517,293 -2,730,294
ONCS's Total Ranking # 4720 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


ONCS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 448
Healthcare Sector # 935
Overall Market # 4720

Net Income per Employee Statistics
High Average Low
$ -1,959,058 $ -2,515,223 $ -3,047,881
(Jan 31 2023)   (Oct 31 2020)







Companies with similar Income per Employee for 12 month ending Jan 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Jan 31 2023Number of Employees Jan 31 2023


Date modified: 2026-09-08T15:10:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.